HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $84.76 billion. The enterprise value is $128.46 billion.
Important Dates
The last earnings date was Friday, January 24, 2025, before market open.
| Earnings Date | Jan 24, 2025 |
| Ex-Dividend Date | Mar 17, 2025 |
Share Statistics
HCA Healthcare has 253.30 million shares outstanding. The number of shares has decreased by -5.28% in one year.
| Current Share Class | 253.30M |
| Shares Outstanding | 253.30M |
| Shares Change (YoY) | -5.28% |
| Shares Change (QoQ) | -1.77% |
| Owned by Insiders (%) | 1.31% |
| Owned by Institutions (%) | 64.24% |
| Float | 180.85M |
Valuation Ratios
The trailing PE ratio is 15.21 and the forward PE ratio is 13.45. HCA Healthcare's PEG ratio is 1.07.
| PE Ratio | 15.21 |
| Forward PE | 13.45 |
| PS Ratio | 1.21 |
| Forward PS | 1.13 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.16 |
| P/OCF Ratio | 8.13 |
| PEG Ratio | 1.07 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.27, with an EV/FCF ratio of 22.78.
| EV / Earnings | 22.30 |
| EV / Sales | 1.82 |
| EV / EBITDA | 9.27 |
| EV / EBIT | 12.18 |
| EV / FCF | 22.78 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 80.89.
| Current Ratio | 1.08 |
| Quick Ratio | 0.84 |
| Debt / Equity | 80.89 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 7.96 |
| Interest Coverage | 5.12 |
Financial Efficiency
Return on equity (ROE) is 824.40% and return on invested capital (ROIC) is 14.92%.
| Return on Equity (ROE) | 824.40% |
| Return on Assets (ROA) | 11.39% |
| Return on Invested Capital (ROIC) | 14.92% |
| Return on Capital Employed (ROCE) | 23.79% |
| Revenue Per Employee | $227,752 |
| Profits Per Employee | $18,581 |
| Employee Count | 310,000 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 22.31 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.87 billion in taxes.
| Income Tax | 1.87B |
| Effective Tax Rate | 21.89% |
Stock Price Statistics
The stock price has increased by +16.70% in the last 52 weeks. The beta is 1.65, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | +16.70% |
| 50-Day Moving Average | 315.78 |
| 200-Day Moving Average | 344.71 |
| Relative Strength Index (RSI) | 63.62 |
| Average Volume (20 Days) | 1,688,536 |
Short Selling Information
The latest short interest is 4.40 million, so 1.74% of the outstanding shares have been sold short.
| Short Interest | 4.40M |
| Short Previous Month | 3.53M |
| Short % of Shares Out | 1.74% |
| Short % of Float | 2.43% |
| Short Ratio (days to cover) | 3.36 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $70.60 billion and earned $5.76 billion in profits. Earnings per share was $22.00.
| Revenue | 70.60B |
| Gross Profit | 28.68B |
| Operating Income | 10.55B |
| Pretax Income | 7.57B |
| Net Income | 5.76B |
| EBITDA | 13.86B |
| EBIT | 10.55B |
| Earnings Per Share (EPS) | $22.00 |
Full Income StatementBalance Sheet
The company has $1.93 billion in cash and $44.89 billion in debt, giving a net cash position of -$42.96 billion or -$169.61 per share.
| Cash & Cash Equivalents | 1.93B |
| Total Debt | 44.89B |
| Net Cash | -42.96B |
| Net Cash Per Share | -$169.61 |
| Equity (Book Value) | 555.00M |
| Book Value Per Share | -9.79 |
| Working Capital | 1.24B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $10.51 billion and capital expenditures -$4.88 billion, giving a free cash flow of $5.64 billion.
| Operating Cash Flow | 10.51B |
| Capital Expenditures | -4.88B |
| Free Cash Flow | 5.64B |
| FCF Per Share | $22.26 |
Full Cash Flow StatementMargins
Gross margin is 40.62%, with operating and profit margins of 14.94% and 8.16%.
| Gross Margin | 40.62% |
| Operating Margin | 14.94% |
| Pretax Margin | 12.07% |
| Profit Margin | 8.16% |
| EBITDA Margin | 19.63% |
| EBIT Margin | 14.94% |
| FCF Margin | 7.99% |